-
Niraparib hydrochloride
- names:
Niraparib hydrochloride
- CAS号:
1038915-64-8
MDL Number: - MF(分子式): C19H21ClN4O MW(分子量): 356.85
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001425-5mg | 5mg | 99.8% | ¥ 1215.00 | ¥ 1215.00 | 2-3天 | ¥ 0.00 | ||
| YZM001425-2mg | 2mg | 99.8% | ¥ 858.00 | ¥ 858.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | Niraparib hydrochloride |
| CAS号 | 1038915-64-8 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C19H21ClN4O |
| 分子量 Molecular Weight | 356.85 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度250 mg/mL(700.57 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Niraparib hydrochloride (MK827 hydrochloride) is a highly potent and orally bioavailablePARP1andPARP2inhibitor withIC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride (MK827 hydrochloride) leads to inhibition of repair of DNA damage and shows antiumor activity[2][3]. |
| Application1 | |
| Application2 | |
| Application3 |
Niraparib hydrochloride (MK-4827 hydrochloride) 是一种有效的,具有口服活性的PARP1和PARP2抑制剂,IC50值分别为 3.8 nM 和 2.1 nM。Niraparib hydrochloride (MK-4827 hydrochloride) 抑制 DNA 损伤修复,并具有抗肿瘤活性。Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailablePARP1andPARP2inhibitor withIC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride (MK-4827 hydrochloride) leads to inhibition of repair of DNA damage and shows anti-tumor activity[1][2][3].
【1】.Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85.
【2】.Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86.
【3】.Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.
【4】.Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
【2】.Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86.
【3】.Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.
【4】.Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


